Reach [orgf]
Target [ftcn]
Lipid level [lbtr]
diabetic [fndg]
{Non-patient} [clna]
diabetic [fndg]
Previous [tmco]
Myocardial Infarction [dsyn]
Introduction [hlca]
Dyslipidaemia [dsyn]
Cardiovascular Diseases [dsyn]
Target [ftcn]
Lipid level [lbtr]
Rarely [qlco]
Reach [orgf]
Every day [tmco]
practice [menp]
Objective [inpr]
Objective [inpr]
Study [mnob]
Evaluate [ftcn]
Often [tmco]
treatment goals [inpr]
Lipid [lipd]
Parameters [fndg]
diabetic [fndg]
{Non-patient} [clna]
diabetic [fndg]
Previous [tmco]
Myocardial Infarction [dsyn]
Methods [inpr]
Survey [inpr]
included [ftcn]
Patients [podg]
Males [fndg]
Females [fndg]
Age-Years [tmco]
diabetics [fndg]
History [ocdi]
Myocardial Infarction [dsyn]
Previous [tmco]
Patients [podg]
Select [acty]
Database [inpr]
Multicenter Study [resa]
prospective [resa]
Interventional [topp]
Secondary Prevention [topp]
coronary heart disease [dsyn]
cerebrovascular diseases [patf]
Conduct [inbe]
Patients [podg]
Serbia [geoa]
Patients [podg]
5th [qnco]
Visit [bhvr]
months [tmco]
Visit [bhvr]
Inclusion [qlco]
Study [mnob]
Lipid [lipd]
Status [qlco]
Lipid lowering drug [phsu]
Independent [idcn]
Prognostic Factor [clna]
adverse events [fndg]
coronary [bpoc]
Identified [qlco]
Beginning [tmco]
Study [mnob]
Patients [podg]
Informed [qlco]
lifestyle change [socb]
Active [ftcn]
Approach [spco]
treatment [ftcn]
Accomplishment [socb]
secondary [neop]
preventive measures [inpr]
Estimated [qnco]
European [popg]
Guidelines [inpr]
Secondary Prevention [topp]
coronary heart disease [dsyn]
Introduction [hlca]
preventive measures [inpr]
diabetics [fndg]
High Prevalence [qnco]
Target [ftcn]
Total Cholesterol [lbpr]
Cholesterol, HDL [bacs, lipd]
diabetics [fndg]
P NOS [aapp, imft]
diabetics [fndg]
High Prevalence [qnco]
Target [ftcn]
Cholesterol, LDL [bacs, strd]
diabetics [fndg]
P NOS [aapp, imft]
treatment goals [inpr]
Triglycerides [bacs, lipd]
diabetic [fndg]
{Non-patient} [clna]
diabetic [fndg]
P NOS [aapp, imft]
End [spco]
Study [mnob]
Apply [hlca]
Secondary Prevention [topp]
Measures [qnco]
diabetics [fndg]
Lipid lowering drug [phsu]
Percentage [qnco]
diabetics [fndg]
Lipid lowering drug [phsu]
Not significant [fndg]
Statistically [ocdi]
P NOS [aapp, imft]
ENTER [ftcn]
Regression Analysis [inpr]
Triglycerides [bacs, lipd]
Cholesterol, LDL [bacs, strd]
Single [popg]
Out [spco]
Independent [idcn]
Prognostic Factor [clna]
adverse events [fndg]
coronary [bpoc]
Study [mnob]
High Prevalence [qnco]
Increased [qnco]
plasma concentration [qnco]
Cholesterol, LDL [bacs, strd]
Triglycerides [bacs, lipd]
plasma concentration [qnco]
Cholesterol, HDL [bacs, lipd]
Insufficient [qlco]
Lipid lowering drug [phsu]
diabetic [fndg]
{Non-patient} [clna]
diabetic [fndg]
Previous [tmco]
Myocardial Infarction [dsyn]
Decreasing [qlco]
Total Cholesterol [lbpr]
Increasing [ftcn]
Cholesterol, HDL [bacs, lipd]
Decreasing [qlco]
Triglycerides [bacs, lipd]
Cholesterol, LDL [bacs, strd]
Secondary Prevention [topp]
Measure [qnco]
cardiovascular events [fndg]
Patients [podg]
Diabetes [dsyn]
